Concern and continuity in the care of cancer patients and their carers: development of the intervention

ISRCTN ISRCTN43339432
DOI https://doi.org/10.1186/ISRCTN43339432
Secondary identifying numbers SDO/13/2001 (e)
Submission date
13/09/2005
Registration date
17/10/2005
Last edited
10/05/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

http://cancerhelp.cancerresearchuk.org/trials/a-study-looking-at-the-continuity-of-care-of-patients-with-cancer

Contact information

Prof Michael King
Scientific

Dept Mental Health Sciences
Royal Free and University College Medical School
Rowland Hill Street
London
NW3 2PF
United Kingdom

+44 (0)20 7794 0500
m.king@medsch.ucl.ac.uk

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeOther
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific title
Study objectivesThat the development and testing of a complex intervention will lead to improved continuity of care in cancer for patients and those close to them by the delivery of the planned intervention.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedContinuity of care in cancer
InterventionA feasibility (phase II) randomised trial in which we are developing and testing a new intervention - this will be a form of care record for teams in which aspects of continuity of care for each patient will be assessed.
ECAP - engagement and continuity action plan: a continuity of care risk assessment completed by secondary care workers at multi-disciplinary meeting.
Intervention typeOther
Primary outcome measure1. Acceptability
2. Practicality and feasibility of ECAP
3. Improved patient experience of engagement with care
Secondary outcome measures1. Economic benefits
2. Patient and nominated friend/family member well being
Overall study start date01/04/2006
Completion date30/09/2007

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants80 patients with up to two nominated relatives or friends
Key inclusion criteria1. Aged over 18 years
2. Able to give informed consent
3. Patients diagnosed with breast, lung or colorectal cancer, or their nominated relative or friend
Key exclusion criteria1. Unable to give informed consent
2. Aged under 18 years
Date of first enrolment01/04/2006
Date of final enrolment30/09/2007

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Dept Mental Health Sciences
London
NW3 2PF
United Kingdom

Sponsor information

University College London (UK)
University/education

Gower Street
London
WC1E 6BT
England
United Kingdom

+44 (0)20 7679 2000
vicky.latter@royalfree.nhs.uk
ROR logo https://ror.org/02jx3x895

Funders

Funder type

Government

NHS Service and Delivery Organisation (UK) [ref: SDO/13/2001 (e)]

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 27/01/2009 Yes No
BMC - Part of Springer Nature Springer Nature